Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Kaniecki

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Clinical Pharmacology|October 1, 1993
Integrating worldwide marketing needs and clinical researchD J Kaniecki, R J Arnold
Southern Medical Journal|February 1, 1993
Selection of oral controlled-release drugs: a critical decision for the physicianR J Arnold, D J Kaniecki
Pharmacoeconomics|November 4, 1992
Pharmacoeconomic considerations in antiarrhythmic therapyP J Podrid, R J Arnold, D J Kaniecki
Pharmacotherapy|March 1, 1994
Cost-effectiveness of antihypertensive agents in patients with reduced left ventricular functionR J Arnold, D J Kaniecki, W H Frishman
The American Journal of Managed Care|June 6, 1997
Pharmacoeconomic analysis of selected antibiotics in lower respiratory tract infectionR W Quenzer, K G Pettit, R J Arnold, et al.
Heart Disease (Hagerstown, Md.)|November 27, 2001
Review of the development, validation, and application of predictive instruments in interventional cardiologyR J Goldberg Arnold, K S Akhras, C Chen, et al.
The American Journal of Gastroenterology|May 16, 2000
Cost of treating an episode of variceal bleeding in a VA settingA Zaman, R J Goldberg, K G Pettit, et al.
Academic Radiology|March 16, 2001
Use of a decision-analytic model to support the use of a new oral US contrast agent in patients with abdominal painR L Bree, R J Arnold, K G Pettit, et al.
The American Journal of Cardiology|December 15, 1991
Comparative cost-effectiveness analysis of quinidine, procainamide and mexiletineP J Podrid, P R Kowey, W H Frishman, et al.
Chest|March 1, 1993
Comparative cost-effectiveness analysis of theophylline and ipratropium bromide in chronic obstructive pulmonary disease. A three-center studyA Jubran, N Gross, J Ramsdell, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Clinical Pharmacology|October 1, 1993
Integrating worldwide marketing needs and clinical researchD J Kaniecki, R J Arnold
Southern Medical Journal|February 1, 1993
Selection of oral controlled-release drugs: a critical decision for the physicianR J Arnold, D J Kaniecki
Pharmacoeconomics|November 4, 1992
Pharmacoeconomic considerations in antiarrhythmic therapyP J Podrid, R J Arnold, D J Kaniecki
Pharmacotherapy|March 1, 1994
Cost-effectiveness of antihypertensive agents in patients with reduced left ventricular functionR J Arnold, D J Kaniecki, W H Frishman
The American Journal of Managed Care|June 6, 1997
Pharmacoeconomic analysis of selected antibiotics in lower respiratory tract infectionR W Quenzer, K G Pettit, R J Arnold, et al.
Heart Disease (Hagerstown, Md.)|November 27, 2001
Review of the development, validation, and application of predictive instruments in interventional cardiologyR J Goldberg Arnold, K S Akhras, C Chen, et al.
The American Journal of Gastroenterology|May 16, 2000
Cost of treating an episode of variceal bleeding in a VA settingA Zaman, R J Goldberg, K G Pettit, et al.
Academic Radiology|March 16, 2001
Use of a decision-analytic model to support the use of a new oral US contrast agent in patients with abdominal painR L Bree, R J Arnold, K G Pettit, et al.
The American Journal of Cardiology|December 15, 1991
Comparative cost-effectiveness analysis of quinidine, procainamide and mexiletineP J Podrid, P R Kowey, W H Frishman, et al.
Chest|March 1, 1993
Comparative cost-effectiveness analysis of theophylline and ipratropium bromide in chronic obstructive pulmonary disease. A three-center studyA Jubran, N Gross, J Ramsdell, et al.
Pageof 1